Healthcare Active runners: Teva Pharmaceutical Industries (NYSE:TEVA), Bristol-Myers Squibb Co (NYSE:BMY), Merck & Co (NYSE:MRK), Sanofi (NYSE:SNY)



Israel-based Teva Pharmaceutical Industries Ltd. (ADR) (NYSE:TEVA) has announced that the U.S. Supreme Court has granted the Company’s Copaxone certiorari petition, and will hear its appeal of a decision from the United States Court of Appeals for the Federal Circuit that invalidated the claim of U.S. Patent 5,800,808. Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) stock performance was 1.39% in last session and finished the day at $54.06. Traded volume was 8.07million shares in the last session and the average volume of the stock remained 7.17million shares. The beta of the stock remained 0.59.

Merck KGaA ( MKGAF ) has been quite active on the collaboration front. Recent deals include an agreement with Bristol-Myers Squibb Company (NYSE:BMY) to co-promote Glucophage for type II diabetes in China and another with BeiGene Co., Ltd. to co-develop and commercialize BeiGene-283. Bristol-Myers Squibb Co (NYSE:BMY) dropped -1.40 percent to $50.87 Thursday on volume of 7.86million shares. The intra-day range of the stock was $50.69 to $51.80. Bristol-Myers Squibb Co (NYSE:BMY) has a market capitalization of $84.29billion.

Mayor Ellen Dickson, the mayor announced reappointment of Celia Colbert, who currently serves as board of education vice president. Colbert, former vice president of corporate strategic markets for Merck & Co. Inc. (NYSE:MRK) is expected to take over as board president in May. Merck & Co., Inc. (NYSE:MRK)’s stock on Apr 03, 2014 reported a decrease of -0.44% to the closing price of $56.21. Its fifty two weeks range is $44.60 -$57.65. The total market capitalization recorded $165.29billion. The overall volume in the last trading session was 8.32million shares. In its share capital, MRK has 2.94billion outstanding shares.

Reuters has reported that Sanofi SA (ADR) (NYSE:SNY) is considering acquisitions in key business units such as consumer and animal health products and expects robust growth in the “strategic continent” of Africa. On Thursday, shares of Sanofi SA (ADR) (NYSE:SNY) advanced 0.04% to close the day at $52.04. Company return on investment (ROI) is 7.20% and its monthly performance is recorded as 0.46%. Sanofi SA (ADR) (NYSE:SNY) quarterly revenue growth is 0.56%.

Signup for free to be the first to receive exclusive free links. Now in your mailbox!
Join over 15,000 subscribers
Send me links

Your information will not be shared to anyone